DEX — Dextech Medical AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK130.33m
- SEK116.25m
Annual balance sheet for Dextech Medical AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 3.46 | 35.5 | 25.2 | 19 | 14.7 |
| Net Total Receivables | 0.033 | 0.204 | 0.111 | 0.133 | 0.091 |
| Total Other Current Assets | |||||
| Total Current Assets | 3.75 | 36 | 25.8 | 19.7 | 15.2 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 7.23 | 39.6 | 35 | 30.6 | 25.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.218 | 0.712 | 0.718 | 0.98 | 0.337 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.218 | 0.712 | 0.718 | 0.98 | 0.337 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 7.02 | 38.9 | 34.3 | 29.6 | 24.8 |
| Total Liabilities & Shareholders' Equity | 7.23 | 39.6 | 35 | 30.6 | 25.1 |
| Total Common Shares Outstanding |